Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Signals for stress erythropoiesis are integrated via an erythropoietin receptor–phosphotyrosine-343–Stat5 axis
Madhu P. Menon, Vinit Karur, Olga Bogacheva, Oleg Bogachev, Bethany Cuetara, Don M. Wojchowski
Madhu P. Menon, Vinit Karur, Olga Bogacheva, Oleg Bogachev, Bethany Cuetara, Don M. Wojchowski
View: Text | PDF
Research Article Hematology

Signals for stress erythropoiesis are integrated via an erythropoietin receptor–phosphotyrosine-343–Stat5 axis

  • Text
  • PDF
Abstract

Anemia due to chronic disease or chemotherapy often is ameliorated by erythropoietin (Epo). Present studies reveal that, unlike steady-state erythropoiesis, erythropoiesis during anemia depends sharply on an Epo receptor–phosphotyrosine-343–Stat5 signaling axis. In mice expressing a phosphotyrosine-null (PY-null) Epo receptor allele (EpoR-HM), severe and persistent anemia was induced by hemolysis or 5-fluorouracil. In short-term transplantation experiments, donor EpoR-HM bone marrow cells also failed to efficiently repopulate the erythroid compartment. In each context, stress erythropoiesis was rescued to WT levels upon the selective restoration of an EpoR PY343 Stat5-binding site (EpoR-H allele). As studied using a unique primary culture system, EpoR-HM erythroblasts exhibited marked stage-specific losses in Epo-dependent growth and survival. EpoR-H PY343 signals restored efficient erythroblast expansion, and the selective Epo induction of the Stat5 target genes proviral integration site-1 (Pim-1) and oncostatin-M. Bcl2-like 1 (Bcl-x), in contrast, was not significantly induced via WT-EpoR, EpoR-HM, or EpoR-H alleles. In Kit+CD71+ erythroblasts, EpoR-PY343 signals furthermore enhanced SCF growth effects, and SCF modulation of Pim-1 kinase and oncostatin-M expression. In maturing Kit–CD71+ erythroblasts, oncostatin-M exerted antiapoptotic effects that likewise depended on EpoR PY343–mediated events. Stress erythropoiesis, therefore, requires stage-specific EpoR-PY343-Stat5 signals, some of which selectively bolster SCF and oncostatin-M action.

Authors

Madhu P. Menon, Vinit Karur, Olga Bogacheva, Oleg Bogachev, Bethany Cuetara, Don M. Wojchowski

×

Figure 5

Options: View larger image (or click on image) Download as PowerPoint
At a Kit+CD71high stage, EpoR-HM erythroblasts exhibit proliferation and...
At a Kit+CD71high stage, EpoR-HM erythroblasts exhibit proliferation and survival defects that are corrected by EpoR-H PY343 signals. (A) Erythroid progenitor cells from WT-EpoR mice were expanded in SP34-EX. At 72 hours of culture, Kit+CD71high erythroblasts were isolated by FACS and plated in methylcellulose. Colonies with CFUe morphologies uniformly formed as shown in the right panels (and as confirmed by benzidine staining, not shown). Magnification, ×250. (B) Isolated Kit+CD71high WT-EpoR, EpoR-HM, and EpoR-H erythroblasts were cultured in SP34-EX in the presence of Epo or SCF at the concentrations indicated. At 20 hours, cytokine-induced 3HdT incorporation rates were determined. For Epo, mean 3HdT incorporation rates ± SD (n = 3) are graphed and are normalized for SCF responsiveness. Results are representative of 2 independent experiments (n = 3 WT-EpoR, EpoR-HM, and EpoR-H mice per experiment). (C) For Kit+CD71high and Kit–CD71high WT-Epo, EpoR-HM, and EpoR-H erythroblasts, frequencies of annexin V–positive cells were assayed by flow cytometry. Values are means ± SD of triplicate analyses (*P < 0.01 vs. WT-EpoR and EpoR-H).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts